Everyone knows that whoever owns the patent for an antibiotic has a treasure trove, so no one wants to miss out.
As the boss, Chen Xia certainly would not participate in the auction in person. He was just watching from the sidelines.
It's okay for other continents, but within Asia, he does not want Srivijaya in Southeast Asia and India to obtain the patent rights.
An inferior nation and country like Srivijaya is not worthy of owning the patented medicine made from pumpkin vines.
Asan is too dishonest in doing business and is proficient in all kinds of cheating and deceiving. From now on, Chen Xia will never get a penny of patent from Asan.
It will be useless for Pumpkin Vine to take back the patent by then. When it comes to drug imitation, India is definitely the world's No. 1, and you can't ban it even if you want.
The final result also made Chen Xia breathe a sigh of relief. Among the three places in the Asian region, except for one won by Japan's Takeda Pharmaceutical, the other two were won by South Korea's Hanmi Pharmaceutical and Baotou's Usa Pharmaceutical.
The patent fee offered by Ukraine is as high as 20%. These wealthy countries are not short of money at all. There is too much oil under the ground. They invested in the pharmaceutical factory mainly for the needs of industrial layout and do not value immediate interests.
Of course, this is an exception. For example, Hanmi Pharmaceutical's patent fee is only 10%.
The situation in other continents is similar, basically hovering around 10%. Among them, Chen Xia’s old friend, Switzerland’s Novartis Pharmaceuticals, also grabbed one of the spots.
If these five antibiotics are released, if nothing unexpected happens, they can generate US$2.5 to US$3 billion in revenue for Four Seasons Group every year.
Chen Xia won without any effort.
Continue read on readnovelmtl.com
